[vc_row][vc_column][vc_column_text]
This list has been updated on April 21, 2022, adding 35 drug patents that are expiring in 2022.
Which drug patents are expiring in 2020?
There are about a dozen websites on the internet answering this very question. We can definitely do better than that. How about the list of drugs that are going off-patent within the next 3 years? Much better. How can we make it even better, say for generic companies?
With the huge growth in the generic drug market, there is no doubt that generic companies (hey there!) are searching for drugs with a soon-to-be-expired label. To make their (your) work easy, we collected not just the drug names but also included other information like yearly sales, treatment, ingredients, and the disease they cure, which could help them (you) easily choose a drug most profitable to develop a generic version.
Without any delay, here is the list of drugs. Thank us later!
The article has a list of drug patents from 2020 to 2022. You can get the drug patents expiration list from 2026 to 2030 in a PDF by filling out the form below.
[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][mk_fancy_title color=”#2878bf” size=”32″ line_height=”80″ font_weight=”bolder” txt_transform=”uppercase” margin_bottom=”0″ font_family=”none”]Patents Expiring in 2020[/mk_fancy_title][mk_divider margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Atrovant HFA
Ipratropium Bromide[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$135 million (2014)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6739333 | May 26, 2020 |
| US6983743 | May 26, 2020 |
[/mk_table][vc_column_text css=”.vc_custom_1578575921755{margin-bottom: 0px !important;}”]Dosage : Aerosol, Metered; Inhalation
Company : Boehringer Ingelheim Pharmaceuticals Inc
Ingredients : Ipratropium Bromide
Treatment : Chronic Obstructive Pulmonary Disease and Asthma
ANDA Filing Company : – [/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Byduredon BCISE
Exenatide[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$283 million (H1,2019)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6414126 | October 04, 2020 |
| US6479065 | August 10, 2020 |
| US6515117 | October 04, 2020 |
| US6667061 | May 25, 2020 |
| US6872700 | January 14, 2020 |
| US6936590 | October 04, 2020 |
| US9198925 | October 04, 2020 |
[/mk_table][vc_column_text css=”.vc_custom_1578566196910{margin-bottom: 0px !important;}”]Dosage : Suspension, Extended Release, Subcutaneous
Company : Astrazeneca Ab
Ingredients : Exenatide
Treatment : Type 2 Diabetes Mellitus
ANDA Filing company : –[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Chantix
Varenicline[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$1.08 billion (2018)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6410550 | November 10, 2020 |
[/mk_table][vc_column_text css=”.vc_custom_1578575836352{margin-bottom: 0px !important;}”]Dosage : Tablet; Oral
Company : Pfizer
Ingredients : Varenicline Tartrate
Treatment : Smoking Cessation
ANDA Filing Companies : Mylan, Ajanta Pharma, Par Pharma, Apotex[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Dexilant
Dexlansoprazole[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$445 Million (2017)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6462058 | December 15, 2020 |
| US6939971 | December 15, 2020 |
| US7285668 | December 15, 2020 |
| US9145389 | June 15, 2020 |
[/mk_table][vc_column_text css=”.vc_custom_1578575788337{margin-bottom: 0px !important;}”]Dosage : Capsule, Delayed Release; Oral
Company : Takeda Pharmaceuticals Usa Inc
Ingredients : Dexlansoprazole
Treatment : Erosive Esophagitis
ANDA Filing Companies : Dr Reddy’s, Impax, Anchen, Twi Pharma[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row]
[vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Inlyta
Axitinib[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$339 million (2017)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7141581 | June 30, 2020 |
[/mk_table][vc_column_text css=”.vc_custom_1578575750655{margin-bottom: 0px !important;}”]Dosage : Tablet; Oral
Company : Pfizer
Ingredients : Axitinib
Treatment : Advanced Renal Cell Carcinoma
ANDA Filing Companies : Apotex, Glenmark[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Safyral
Drospirenone; Ethinyl Estradiol; Levomefolate[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$22 million (2017)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6441168 | April 17, 2020 |
[/mk_table][vc_column_text css=”.vc_custom_1578575699297{margin-bottom: 0px !important;}”]Dosage : Tablet; Oral
Company : Bayer Healthcare Pharmaceuticals Inc
Ingredients : Drospirenone; Ethinyl Estradiol; Levomefolate Calcium
Treatment : Oral Contraceptive
ANDA Filing Companies : Lupin, Watson[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Saphris
Asenapine[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$139.7 million (2018)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US5763476 | December 09, 2020 |
[/mk_table][vc_column_text css=”.vc_custom_1578575662129{margin-bottom: 0px !important;}”]Dosage : Tablet; Sublingual
Company : Allergan Llc
Ingredients : Asenapine Maleate
Treatment : Antipsychotic
ANDA Filing Companies : Alembic, Amneal, Breckenridge, Hikma, SigmaPharma[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Silenor
Doxepin[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$22.3 million (2017)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6211229 | February 17, 2020 |
[/mk_table][vc_column_text css=”.vc_custom_1578575607170{margin-bottom: 0px !important;}”]Dosage : Tablet; Sublingual
Company : Currax Pharmaceuticals Llc
Ingredients : Doxepin Hydrochloride
Treatment : Sleep Problem (Insomnia)
ANDA Filing Companies : Par Pharma, Actavis, Mylan, Zydus Cadila[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sprycel
Dasatinib[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$536 million (2018)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6596746 | December 28, 2020 |
| US7125875 | October 13, 2020 |
| US7153856 | October 28, 2020 |
[/mk_table][vc_column_text css=”.vc_custom_1578575555977{margin-bottom: 0px !important;}”]Dosage : Tablet; Oral
Company : Bristol Myers Squibb Co
Ingredients : Dasatinib
Treatment : Cancer (chronic myeloid leukemia-CML, acute lymphoblastic leukemia-ALL
ANDA Filing Companies : Apotex, Dr Reddy’s[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Vigamox
Moxifloxacin[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$267.9 million (2017)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6716830 | March 29, 2020 |
| US7671070 | March 29, 2020 |
[/mk_table][vc_column_text css=”.vc_custom_1578575505942{margin-bottom: 0px !important;}”]Dosage : Solution/Drops; Ophthalmic
Company : Novartis Pharmaceuticals Corp
Ingredients : Moxifloxacin Hydrochloride
Treatment : Bacterial Conjunctivitis
ANDA Filing Companies : Teva, Watson, Lupin, Apotex, Aurobindo, Akorn, Alembic[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Xarelto
Rivaroxaban[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$6.58 billion (2018)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7585860 | December 11, 2020 |
| US7592339 | June 24, 2022 |
[/mk_table][vc_column_text css=”.vc_custom_1578575450593{margin-bottom: 0px !important;}”]Dosage : Tablet; Oral
Company : Janssen Pharmaceuticals Inc
Ingredients : Rivaroxaban
Treatment : Stroke and systemic embolism with nonvalvular atrial fibrillation
ANDA Filing Companies : Aurobindo, Breckenridge, Microlabs, Mylan, SigmaPharma, Torrent, Prinston Pharma, Sun (Taro), Teva, Alembic, Invagen, Lupin, Macleods, Accord (Intas), Hec Pharma[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][mk_fancy_title color=”#2878bf” size=”32″ line_height=”80″ font_weight=”bolder” txt_transform=”uppercase” margin_bottom=”0″ font_family=”none”]Patents Expiring in 2021[/mk_fancy_title][mk_divider margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Bystolic
Nebivolol[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$585.8 million (2018)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6545040 | December 17, 2021 |
[/mk_table][vc_column_text css=”.vc_custom_1578575358023{margin-bottom: 0px !important;}”]Dosage : Tablet; Oral
Company : Allergan Llc
Ingredients : Nebivolol Hydrochloride
Treatment : Hypertension
ANDA Filing Companies : Amerigen Pharma, Glenmark, Hetero, Torrent, Watson, Alkem, Aurobindo[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Crixivan
Indinavir[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
–[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6689761 | February 10, 2021 |
[/mk_table][vc_column_text css=”.vc_custom_1578572901326{margin-bottom: 0px !important;}”]Dosage : Capsule; Oral
Company : Merck Sharp And Dohme Corp
Ingredients : Indinavir Sulfate
Treatment : HIV
ANDA Filing company : -[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Emtriva
Emtricitabine[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$15 million (2018)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6642245 | May 04, 2021 |
| US6703396 | September 09, 2021 |
[/mk_table][vc_column_text css=”.vc_custom_1578575265534{margin-bottom: 0px !important;}”]Dosage : Capsule; Oral
Company : Gilead Sciences Inc
Ingredients : Emtricitabine
Treatment : Combination with other antiretroviral agents, for the treatment of HIV-1 infection
ANDA Filing Companies : Cipla, Aurobindo[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Hysingla ER
Hydrocodone er[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$447 million (2017)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6733783 | October 30, 2021 |
| US8361499 | October 30, 2021 |
| US8551520 | October 30, 2021 |
| US8647667 | October 30, 2021 |
[/mk_table][vc_column_text css=”.vc_custom_1578575224294{margin-bottom: 0px !important;}”]Dosage : Tablet, Extended Release; Oral
Company : Purdue Pharma Lp
Ingredients : Hydrocodone Bitartrate
Treatment : Severe Pain, Opioid (narcotic) Analgesics
ANDA Filing Companies : Alvogen, Mylan[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Perforomist
Formoterol[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
–[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6667344 | June 22, 2021 |
| US6814953 | June 22, 2021 |
| US7348362 | June 22, 2021 |
| US7462645 | June 22, 2021 |
| US8623922 | June 22, 2021 |
| US9730890 | June 22, 2021 |
[/mk_table][vc_column_text css=”.vc_custom_1578575185664{margin-bottom: 0px !important;}”]Dosage : Solution; Inhalation
Company : Mylan Specialty Lp
Ingredients : Formoterol Fumarate
Treatment : Chronic Obstructive Pulmonary Disease including Chronic Bronchitis and Emphysema
ANDA Filing Company : Teva[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sutent
Sunitinib[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]
Sales:
$264 million (2018)
[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6573293 | August 15, 2021 |
| US7125905 | August 15, 2021 |
| US7211600 | June 22, 2021 |
[/mk_table][vc_column_text css=”.vc_custom_1578575153156{margin-bottom: 0px !important;}”]Dosage : Capsule; Oral
Company : Pfizer
Ingredients : Sunitinib Malate
Treatment : Cancer (kidney, pancreas, and intestinal)
ANDA Filing Company : Mylan[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Zomig ns
Zolmitriptan[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$43.1 million (2018)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6750237 | May 28, 2021 |
| US7220767 | May 28, 2021 |
[/mk_table][vc_column_text css=”.vc_custom_1578575046204{margin-bottom: 0px !important;}”]Dosage : Spray; Nasal
Company : Astrazeneca Pharmaceuticals Lp
Ingredients : Zolmitriptan
Treatment : Migraine
ANDA Filing Companies : Lannett, Par Pharma[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][mk_fancy_title color=”#2878bf” size=”32″ line_height=”80″ font_weight=”bolder” txt_transform=”uppercase” margin_bottom=”0″ font_family=”none”]Patents Expiring in 2022[/mk_fancy_title][mk_divider margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Januvia
Sitagliptin[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$3.68 billion (2018)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6699871 | July 26, 2022 |
| US7125873 | July 26, 2022 |
[/mk_table][vc_column_text css=”.vc_custom_1578575091196{margin-bottom: 0px !important;}”]Dosage : Tablet; Oral
Company : Merck Sharp And Dohme Corp
Ingredients : Sitagliptin Phosphate
Treatment : Type 2 Diabetes Mellitus
ANDA Filing Companies : Apotex, Mylan, Sandoz, Sun Pharma, Teva, Watson, Zydus Cadila[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Pristiq
Desvenlafaxine[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$206 million (2018)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6673838 | March 01, 2022 |
| US8269040 | July 5, 2027 |
[/mk_table][vc_column_text css=”.vc_custom_1578574950844{margin-bottom: 0px !important;}”]Dosage : Tablet, Extended Release; Oral
Company : Pfizer
Ingredients : Desvenlafaxine Succinate
Treatment : Major Depressive Disorder
ANDA Filing Companies : Anchen, Apotex, Dr Reddy’s, Lupin, Mylan, Roxane, Sandoz, Teva, Watson, Intelli Pharma, Wockhardt, Zydus Cadila, Alembic (Breckenridge)[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Vimovo
Esomeprazole/Naproxen[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]
Sales:
$67.6 million (2018)
[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8557285 | May 31, 2022 |
| US8852636 | May 31, 2022 |
| US8858996 | May 31, 2022 |
| US9161920 | May 31, 2022 |
| US9198888 | May 31, 2022 |
| US9345695 | May 31, 2022 |
| US9707181 | May 31, 2022 |
[/mk_table][vc_column_text css=”.vc_custom_1578574254647{margin-bottom: 0px !important;}”]Dosage : Tablet, Delayed Release; Oral
Company : Horizon Medicines Llc
Ingredients : Esomeprazole Magnesium; Naproxen
Treatment : Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis
ANDA Filing Companies : -[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Vimpat
Lacosamide[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
€ 1.1 billion (2018)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| USRE38551 | March 17, 2022 |
[/mk_table][vc_column_text css=”.vc_custom_1578574506457{margin-bottom: 0px !important;}”]Dosage : Tablet; Oral
Company : Ucb Inc
Ingredients : Lacosamide
Treatment : Epilepsy and Partial-onset Seizures
ANDA Filing Companies : Alembic, Amneal, Aurobindo, Breckenridge, Glenmark, Hetero, Mylan, Sandoz, Sun (Ranbaxy), Teva, Watson, Zydus Cadila[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Givlaari
Givosiran[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$55 Million (2020)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8546143 | January 9, 2022 |
| US9708610 | January 1, 2024 |
| US10273477 | March 8, 2024 |
| US9708615 | March 8, 2024 |
| US9150605 | August 28, 2025 |
| US10131907 | August 24, 2028 |
| US8828956 | December 4, 2028 |
| US8106022 | December 12, 2029 |
| US10125364 | March 15, 2033 |
| US9133461 | May 14, 2033 |
| US10119143 | October 3, 2034 |
| US11028392 | October 3, 2034 |
[/mk_table][vc_column_text css=”.vc_custom_1650538460779{margin-bottom: 0px !important;}”]Dosage: Subcutaneous injection
Company: Alnylam Pharmaceuticals
Ingredients: GIVOSIRAN SODIUM
Treatment: Acute Hepatic Porphyria[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Fusilev
Levoleucovorin[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$400K (2018)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6500829 | March 7, 2022 |
[/mk_table][vc_column_text css=”.vc_custom_1650538596128{margin-bottom: 0px !important;}”]Dosage: Subcutaneous injection
Company: Spectrum Pharma
Ingredients: LEVOLEUCOVORIN CALCIUM
Treatment: Methotrexate[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Leqvio
Inclisiran[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
–[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US9074213 | March 9, 2022 |
| US8232383 | February 20, 2023 |
| US11078485 | November 4, 2023 |
| US10669544 | March 8, 2024 |
| US8809292 | May 10, 2027 |
| US9370582 | December 4, 2028 |
| US10806791 | December 4, 2028 |
| US10125369 | August 18, 2034 |
[/mk_table][vc_column_text css=”.vc_custom_1650538821366{margin-bottom: 0px !important;}”]Dosage: Subcutaneous injection
Company: Novartis
Ingredients: INCLISIRAN SODIUM
Treatment: Atherosclerotic Cardiovascular Disease and Heterozygous Familial Hypercholesterolemia [/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]
Lexiscan
Regadenoson
[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$694 Million (2019)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6403567 | April 10, 2022 |
| US8106183 | February 2, 2027 |
[/mk_table][vc_column_text css=”.vc_custom_1650538963976{margin-bottom: 0px !important;}”]Dosage: Intravenous injection
Company: Astellas Pharma
Ingredients: REGADENOSON
Treatment: Myocardial Perfusion Imaging[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Teflaro
Ceftaroline fosamil[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$153 Million (2019)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6417175 | April 11, 2022 |
[/mk_table][vc_column_text css=”.vc_custom_1650539091083{margin-bottom: 0px !important;}”]Dosage: Intravenous injection
Company: Allergan
Ingredients: CEFTAROLINE FOSAMIL
Treatment: Methicillin-resistant Staphylococcus Aureus (MRSA)[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Combigan
Brimonidine / Timolol[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$522 Million (2019)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7642258 | April 19, 2022 |
[/mk_table][vc_column_text css=”.vc_custom_1650539198578{margin-bottom: 0px !important;}”]Dosage: Eye Drops
Company: Allergan
Ingredients: BRIMONIDINE TARTRATE; TIMOLOL MALEATE
Treatment: Glaucoma[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Cerdelga
Eliglustat[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
€219 million (2020)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6916802 | April 29, 2022 |
| US7196205 | June 26, 2026 |
[/mk_table][vc_column_text css=”.vc_custom_1650539404760{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Genzyme Corporation
Ingredients: ELIGLUSTAT TARTRATE
Treatment: Gaucher’s disease[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Lynparza
Olaparib[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$1.78 Billion (2020)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7151102 | April 29, 2022 |
| US7449464 | October 11, 2024 |
| US7981889 | October 11, 2024 |
| US8247416 | September 24, 2028 |
[/mk_table][vc_column_text css=”.vc_custom_1650539559018{margin-bottom: 0px !important;}”]Dosage: Oral
Company: AstraZeneca
Ingredients: OLAPARIB
Treatment: BRCA-mutated Advanced Ovarian Cancer [/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Epidiolex
Cannabidiol[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$463.6 million (2021)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US10195159 | May 7, 2022 |
| US11096905 | October 14, 2035 |
| US11207292 | April 26, 2039 |
[/mk_table][vc_column_text css=”.vc_custom_1650539700824{margin-bottom: 0px !important;}”]Dosage: Oral, Inhaled
Company: Greenwich Biosciences
Ingredients: CANNABIDIOL
Treatment: Seizures Associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis [/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Fycompa
Perampanel[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$401 million (2018)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6949571 | June 8, 2022 |
| US8772497 | July 1, 2026 |
[/mk_table][vc_column_text css=”.vc_custom_1650539829765{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Eisai Inc.
Ingredients: PERAMPANEL
Treatment: Partial Seizures and Generalized tonic-clonic seizures [/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#0808bf” size=”16″ font_family=”none”]Trulance
Plecanatide[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$82 Million (2020)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7799897 | June 9, 2022 |
| US7041786 | January 30, 2028 |
| US10011637 | June 5, 2034 |
[/mk_table][vc_column_text css=”.vc_custom_1650539978960{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Salix Pharmaceuticals
Ingredients: PLECANATIDE
Treatment: Chronic Idiopathic Constipation and Irritable Bowel Syndrome[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Pepaxto
Melphalan flufenamide[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
–[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6992207 | June 25, 2022 |
[/mk_table][vc_column_text css=”.vc_custom_1650540104695{margin-bottom: 0px !important;}”]Dosage: –
Company: Oncopeptides
Ingredients: MELPHALAN FLUFENAMIDE HYDROCHLORIDE
Treatment: Multiple Myeloma[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Caprelsa
Vandetanib[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
–[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| USRE42353 | June 27, 2022 |
[/mk_table][vc_column_text css=”.vc_custom_1650540195629{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Genzyme Corporation
Ingredients: VANDETANIB
Treatment: Medullary thyroid cancer[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Stivarga
Regorafenib[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
€411 Million (2019)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7351834 | June 28, 2022 |
| US8637553 | February 16, 2031 |
| US9957232 | July 9, 2032 |
[/mk_table][vc_column_text css=”.vc_custom_1650540322568{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Bayer
Ingredients: REGORAFENIB
Treatment: Metastatic Colorectal Cancer[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Lusedra
Fospropofol[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
–[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6204257 | July 1, 2022 |
[/mk_table][vc_column_text css=”.vc_custom_1650540541049{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Eisai Inc.
Ingredients: FOSPROPOFOL DISODIUM
Treatment: Used in Diagnostic or Therapeutic procedures such as Endoscopy[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Folotyn
Pralatrexate[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$48 Million (2018)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6028071 | July 16, 2022 |
[/mk_table][vc_column_text css=”.vc_custom_1650540649178{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Acrotech Biopharma
Ingredients: PRALATREXATE
Treatment: Relapsed or refractory peripheral T-cell lymphoma[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Velcade
Bortezomib[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$930 Million (2020)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6958319 | July 25, 2022 |
| US6713446 | July 25, 2022 |
[/mk_table][vc_column_text css=”.vc_custom_1650540773034{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Takeda
Ingredients: BORTEZOMIB
Treatment: Multiple myeloma and mantle cell lymphoma[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Slynd
Drospirenone[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$30 Million (2020)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6441168 | July 30, 2022 |
[/mk_table][vc_column_text css=”.vc_custom_1650540910662{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Exeltis USA, Inc.
Ingredients: DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
Treatment: Birth control pills to prevent pregnancy[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Macrilen
Macimorelin[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
–[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6861409 | August 1, 2022 |
[/mk_table][vc_column_text css=”.vc_custom_1650541019379{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Æterna Zentaris
Ingredients: MACIMORELIN ACETATE
Treatment: Growth hormone deficiency[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Addyi
Flibanserin[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
–[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7420057 | August 1, 2022 |
[/mk_table][vc_column_text css=”.vc_custom_1650541117917{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Sprout Pharmaceuticals
Ingredients: FLIBANSERIN
Treatment: Pre-menopausal women with hypoactive sexual desire disorder [/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Nucynta
Tapentadol[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$239.5 million (2017)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| USRE39593 | August 5, 2022 |
| US7994364 | June 27, 2025 |
[/mk_table][vc_column_text css=”.vc_custom_1650541258140{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Collegium Pharmaceutical
Ingredients: TAPENTADOL HYDROCHLORIDE
Treatment: Moderate to severe pain for both acute and chronic musculoskeletal pain [/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Bylvay
Odevixibat[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$7 Million (2021)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7132416 | September 5, 2022 |
| US10975046 | June 20, 2039 |
[/mk_table][vc_column_text css=”.vc_custom_1650541373293{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Albireo Pharma
Ingredients: ODEVIXIBAT
Treatment: Progressive familial intrahepatic cholestasis [/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Abilify
Aripiprazole[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$332 Million (2020)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8993761 | September 5, 2022 |
| US9359302 | September 25, 2022 |
| US8642760 | March 25, 2023 |
| US8580796 | March 25, 2023 |
| US8399469 | June 29, 2025 |
| US10112903 | June 24, 2030 |
| US8431576 | October 26, 2030 |
[/mk_table][vc_column_text css=”.vc_custom_1650541558310{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Otsuka America Pharmaceutical
Ingredients: ARIPIPRAZOLE
Treatment: Schizophrenia and bipolar disorder [/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Myrbetriq
Mirabegron[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$1.5 Billion (2018)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6346532 | September 27, 2022 |
| US7342117 | May 4, 2024 |
[/mk_table][vc_column_text css=”.vc_custom_1650545506439{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Astellas Pharma
Ingredients: MIRABEGRON
Treatment: Overactive bladder [/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Lupkynis
Voclosporin[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$45.5 Million (2021)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7332472 | October 17, 2022 |
[/mk_table][vc_column_text css=”.vc_custom_1650545833189{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Aurinia Pharmaceuticals
Ingredients: VOCLOSPORIN
Treatment: Attack of lupus nephritis [/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Movantik
Naloxegol[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$96 Million (2019)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7662365 | October 18, 2022 |
| US7786133 | September 16, 2028 |
| US9012469 | April 2, 2032 |
[/mk_table][vc_column_text css=”.vc_custom_1650546011662{margin-bottom: 0px !important;}”]Dosage: Oral
Company: AstraZeneca
Ingredients: NALOXEGOL OXALATE
Treatment: Opioid-induced constipation [/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Neurontin
Gabapentin[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
–[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8048917 | November 6, 2022 |
| US6818787 | April 6, 2025 |
| US8026279 | November 10, 2026 |
[/mk_table][vc_column_text css=”.vc_custom_1650546316773{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Pfizer
Ingredients: GABAPENTIN ENACARBIL
Treatment: Partial seizures and neuropathic pain [/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Chantix
Varenicline[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$1.1 Billion (2019)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6890927 | November 6, 2022 |
| US7265119 | February 3, 2023 |
[/mk_table][vc_column_text css=”.vc_custom_1650546381299{margin-bottom: 0px !important;}”]Dosage: Nasal spray
Company: Pfizer
Ingredients: VARENICLINE TARTRATE
Treatment: Smoking cessation [/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Ocaliva
Obeticholic acid[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$363.5 million (2021)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7138390 | November 16, 2022 |
| USRE48286 | February 21, 2027 |
| US10174073 | June 17, 2033 |
[/mk_table][vc_column_text css=”.vc_custom_1650546558868{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Intercept Pharmaceuticals
Ingredients: OBETICHOLIC ACID
Treatment: Primary biliary cholangitis [/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Norvasc
Amlodipine[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
–[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US6828339 | November 20, 2022 |
| US6696481 | April 15, 2023 |
| US7846961 | October 5, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1650546716951{margin-bottom: 0px !important;}”]Dosage: Oral
Company: VIATRIS
Ingredients: AMLODIPINE BESYLATE
Treatment: High blood pressure and coronary artery disease [/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Viibryd
Vilazodone[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
–[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7834020 | December 5, 2022 |
| US8673921 | December 5, 2022 |
[/mk_table][vc_column_text css=”.vc_custom_1650546831355{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Allergan
Ingredients: VILAZODONE HYDROCHLORIDE
Treatment: Major depressive disorder [/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Taflotan
Tafluprost [/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$180 Million (2020) Est.[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US5886035 | December 18, 2022 |
[/mk_table][vc_column_text css=”.vc_custom_1650547109217{margin-bottom: 0px !important;}”]Dosage: Eye Drops
Company: Santen Pharmaceutical
Ingredients: TAFLUPROST
Treatment: Open-angle Glaucoma [/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Hetlioz
Tasimelteon[/mk_fancy_title][/vc_column_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sales:
$173.5 Million (2021)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US5856529 | December 9, 2022 |
| US10829465 | February 12, 2035 |
| US10071977 | February 12, 2035 |
[/mk_table][vc_column_text css=”.vc_custom_1650546986787{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Vanda Pharmaceuticals
Ingredients: TASIMELTEON
Treatment: Non-24-hour sleep-wake disorder [/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1579766245476{margin-bottom: 0px !important;}”]Conclusion
Gathering information is one thing and using it is another. Finding such lists on the internet is easy but generating generic versions is no cakewalk. There still lies threats and hurdles that a generic company will face depending on the drug they choose for the generic version.
But there is not much to fret about. With a proper threat analysis, developing a generic version should not give you nightmares anymore. How to go about it? Well, that’s what we are here for. For starters, get in touch by filling out the short form below and our team will reach out to you in no time.
Authored by: Divya Goyal, Team Lead, Life Science Team[/vc_column_text][/vc_column][/vc_row]
